Literature DB >> 22499155

Cardiac sarcoid: a clinician's review on how to approach the patient with cardiac sarcoid.

Nicholas Mantini1, Byron Williams, Jim Stewart, Leon Rubinsztain, Andro Kacharava.   

Abstract

Cardiac sarcoid is an infiltrative, granulomatous disease of the myocardium. It is more prevalent entity than once believed, especially subclinical disease. It affects heart mechanics causing ventricular failure, and disrupts the cardiac electrical system leading to third degree heart block, malignant ventricular arrhythmias, and sudden cardiac death. This makes early diagnosis and treatment of this devastating disease essential. Based on reviewed literature this paper proposes step-wise diagnostic and therapeutic algorithms for patients with suspected cardiac sarcoidoisis who do or do not have prior history of systemic sarcoidosis.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499155      PMCID: PMC6652737          DOI: 10.1002/clc.21982

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  18 in total

1.  Phase-4 paroxysmal atrioventricular block in sarcoidosis.

Authors:  B Sensoy; O Ozeke; U Canpolat; A Colak; E Grbovic; S Cay; S Topaloglu; D Aras; S Aydogdu
Journal:  Herz       Date:  2013-12-04       Impact factor: 1.443

2.  Cardiac sarcoidosis presenting as constrictive pericarditis.

Authors:  Saba Darda; Marcel E Zughaib; Patrick B Alexander; Christian E Machado; Shukri W David; Souheil Saba
Journal:  Tex Heart Inst J       Date:  2014-06-01

3.  Right ventricular cardiomyopathy meeting the arrhythmogenic right ventricular dysplasia revised criteria? Don't forget sarcoidosis!

Authors:  Sabina Vasaturo; David E Ploeg; Guadalupe Buitrago; Katja Zeppenfeld; Maud Veselic-Charvat; Lucia J M Kroft
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 4.  Cardiac sarcoidosis.

Authors:  Matthew M Zipse; William H Sauer
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 5.  18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Authors:  Hicham Skali; Allison R Schulman; Sharmila Dorbala
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

6.  A case report of steroid resistant cardiac sarcoidosis successfully managed with methotrexate.

Authors:  Olga Grabowska; Magdalena M Martusewicz-Boros; Dorota Piotrowska-Kownacka; Elżbieta Wiatr
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

7.  FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation.

Authors:  Darshan C Patel; Senthil S Gunasekaran; Christopher Goettl; Nadera J Sweiss; Yang Lu
Journal:  J Nucl Cardiol       Date:  2017-07-05       Impact factor: 5.952

Review 8.  Echocardiography in Sarcoidosis.

Authors:  Reto Kurmann; Sunil V Mankad; Rekha Mankad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

9.  Role of Cardiac MRI in the Assessment of Cardiomyopathy.

Authors:  Róisín B Morgan; Raymond Kwong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

Review 10.  Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.

Authors:  Hamayak Sisakian
Journal:  World J Cardiol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.